Stock Events

Stock Events

Heron Therapeutics (AXD2.F) Q4 2024 Earnings

12NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.14

-0.1

-0.06

-0.02

Details

Expected EPS

-0.03567635625

Actual EPS

-0.0282585

Surprise EPS

0.01

Surprise Percent

+20.79%

Description

Heron Therapeutics (AXD2.F) has reported earnings of -0.0282585 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.